Document is current
Any future updates will be listed below
-
Authors
Ortuño-Costela, M. Carmen https://orcid.org/0000-0001-9593-775X
Pinzani, Massimo https://orcid.org/0000-0003-1398-1541
Vallier, Ludovic https://orcid.org/0000-0002-3848-2602
- License Information
-
More Information
Article History
Accepted: 11 February 2025
First Online: 18 March 2025
Competing interests
: L.V. is a shareholder of bit.bio and Bilitech. Both companies developed cell-based therapies against liver diseases. M.P. is a cofounder, shareholder, and consultant for Engitix Therapeutics. M.C.O.-C. declares no competing interests.
